Shadow Robot Company Launches Robotics Consulting and Advisory Services

The Shadow Robot Company, the UK’s pioneering robotics company best-known for its Dextrous Hand series, today announced the launch of its Robotics Consultancy Service.

The Shadow Robot Company, a London-based robotics company that designs and manufactures state-of-the-art anthropomorphic robot hands and systems, is launching its robotics consultancy service to help companies innovate by integrating robotic hand technology into their products and processes.

The robotics consultancy service will provide companies with expert advice and guidance on how to design and use robotic hand technology to enhance their performance, efficiency, and competitiveness. The service will also offer customised solutions and support for specific challenges and needs, thanks to its inhouse engineering and production facilities and teams.

  • The range of services include:
    Technical expertise – advising on all aspects of robotic hand design, development, and deployment, including feasibility studies, prototyping, testing and validation.
  • System integration – integrating robotic hands into existing systems through hardware and software solutions, as well as training and support.
  • Application development: developing applications for robotic hands into new products and processes or improving existing ones.

The Shadow Robot Company’s Director, Rich Walker, said: “We are excited to launch our robotics consultancy service and share our expertise and knowledge with other companies who want to innovate with robotic hand technology. We’ve been pleased to see the number of companies developing their own robot hands, and we want to offer the expertise of the ‘best in class’ robot hand developers to the wider community.

“We believe that robotic hand technologies have enormous potential to transform various industries and sectors, and we are eager to help our clients achieve their goals and visions,” he added.

The Shadow Robot Company has more than 20 years of experience in designing and developing robotic systems for research and industry. The company has worked with clients such as NASA, ESA, OpenAI, Google Brain, MIT, University of Oxford, University of Cambridge, and many others.

The company has also won several awards for its innovation and excellence in robotics, such as the Queen’s Award for Enterprise for Innovation in 2019, the AIconics Award for Best Innovation in AI Hardware in 2019 and the E&T Innovation Awards for Excellence in R&D, Intelligent Systems and Tech for Good in 2020.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version